Nomura Recap of Stocks to Look Out For
February 19, 2015 at 20:01 PM EST
Analyst M. Ian Somaiya at Nomura upgraded Pharmacyclics (NASDAQ: PCYC) from Neutral to Buy, while raising the price target from $195 to ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|